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a b s t r a c t
Aims: The evidence on the prevalence and distribution of diabetes and its determinants in
Central Asia is sparse. The aim of the present study was to investigate the prevalence,
awareness, treatment, and control of diabetes and factors associated with these character-
istics in the population of Astana (capital) city and adjacent rural area in Kazakhstan.
Methods: Participants aged 50-75 years old, residing in Astana city (the capital) and Akmol
village were invited to participate in a cross-sectional study. The subjects were randomly
selected from polyclinic registers. A total of 953 adults were interviewed (response rate 59%),
and their fasting plasma glucose, blood pressure, height and weight were measured.
Diabetes was defined as fasting plasma glucose (FPG) 7.0 mmol/l (126 mg/dl) and/or being
on diabetes medication.
Results: The overall prevalence of diabetes was 12.5%, and it was almost twice higher in the
urban residents (16.3%) than in the rural population (8.6%). Diabetes prevalence was
associated with age, men sex, hypertension, obesity, and Russian ethnicity. Among subjects
with diabetes, 72.3% were aware of their condition; 65.6% were on treatment and 27.7% had
controlled fasting plasma glucose. The awareness, treatment and control of diabetes were
substantially higher in the urban population and among women.
Conclusions: The large differences in all diabetes indices between urban and rural regions, if
confirmed in larger studies, may suggest an impact of westernised and urbanised lifestyle as
well as access to health care.
# 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Diabetes is a serious chronic metabolic disorder and an
important modifiable risk factor for cardiovascular diseases.
[1] According to WHO, the prevalence of diabetes has been* Corresponding author. Department of Epidemiology and Public H
WC1E 6BT, United Kingdom. Tel.: +44 20 3108 3021.
E-mail address: m.bobak@ucl.ac.uk (M. Bobak).
http://dx.doi.org/10.1016/j.diabres.2015.11.011
0168-8227/# 2015 The Authors. Published by Elsevier Ireland Ltd. Thi
creativecommons.org/licenses/by-nc-nd/4.0/).increasing rapidly over the last decades and at present time
the estimated global prevalence of diabetes is around 9%. [2]
The International Diabetes Federation projections predict that
the prevalence of diabetes will increase to 8.8% by 2035
worldwide [3]. The burden of ill health due to diabetes has
also been increasing, primarily in developing world; in 2014,ealth, University College London, 1-19 Torrington Place, London
s is an open access article under the CC BY-NC-ND license (http://
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80% of these deaths occurred in low- and middle-income
countries [4].
Most of the research on diabetes and related cardio-
metabolic risk factors has been conducted in western
countries. There is very little evidence on the situation in
Central Asia and Kazakhstan. [5–8] Based on routine statistics,
the age-standardized prevalence of diabetes (raised fasting
blood glucose > = 7.0 mmol/l or on medication for raised blood
glucose) in Kazakhstan was estimated as 13.2% [9], which is
higher compared to Europe (8.3%) but also higher than in the
Russian Federation (9.0%). Similarly, age-standardized mor-
tality from diabetes in Kazakhstan is about double of that in
Russia (10.1 vs. 4.5 per 100,000) [9].
A number of risk factors have been found to be associated
with the increased risk of diabetes, such as eating behaviours,
physical activity and obesity [10], as well as a wide range of
socioeconomic factors. [11,12] Many risk factors for non-
communicable diseases, including diabetes, are linked with
urbanization [13,14], but there is little evidence on the levels of
diabetes and related factors in urban and rural populations in
Central Asia. The rapid societal transformation after the
dissolution of USSR was accompanied by fast introduction of
western diet and lifestyle, particularly in urban settings, and
growing social and economic differences between urban and
rural areas. Providing the evidence on the rates of diabetes and
associated factors in these rapidly changing societies is
important, since modifying these risk factors may provide
many opportunities to prevent diabetes and appropriate
management of diabetes reduces diabetes-attributable com-
plications and mortality [15,16].
The aim of the study was to address this evidence gap and
to investigate prevalence, awareness, treatment, and control
of diabetes and to identify the factors associated with these
characteristics in the general population samples of urban and
rural areas in the Astana region, Kazakhstan.
2. Materials and Methods
2.1. Study population
We conducted a cross-sectional study in Astana city (the new
state capital, population 858,302, population density 1188
persons/km2) and the Akmol village (about 50 km from
Astana, population 6,000, population density in the region
7.7 persons/km2) between November 2012 and March 2015.
The study sample was randomly selected (after stratifying
for age and 5-year age group) from lists of all inhabitants in the
age range 50-74 years (reflecting the overall focus on healthy
ageing) who were registered at a local polyclinic (such
registration is mandatory in Kazakhstan). Participants were
invited by calling their landline telephone; if there was no
landline telephone number, then participants were visited at
home and invited to participate in the study. A total of 953 of
adults aged 50-75 years were recruited (478 in Astana city and
475 in Akmol). The response rate was 59% (56% urban and 63% in
rural area). The study protocol was approved by the ethical
committee of the Center for Life Sciences, Nazarbayev Univer-
sity, and each participant provided a signed informed consent.Data were collected during a visit to a polyclinic by
standardized questionnaire administered by trained practi-
tioners and a brief physical examination. The questionnaire
included an overall assessment of the patient’s health,
medical history, lifestyle and socio-economic indicators. All
questions were translated from English into both Russian and
Kazakh languages and back into English to check for accuracy.
Blood pressure and anthropometric measures were taken
(including height, weight, waist and hip circumference). A
venous blood sample was collected.
2.2. Measurements
Diabetes was defined as fasting plasma glucose (FPG)
concentration 7.0 mmol/l (126 mg/dl) or self-reported diabe-
tes medication use; the questionnaire did not specify the type
of diabetes (1 or 2). For assessment of FPG, subjects were
invited to visit the polyclinic early in the morning after an
overnight fast. The fasting status of the subjects was recorded,
and those who did not meet the above requirements were
invited to visit the polyclinic on another day. Diabetes
awareness was assessed by the question whether the subjects
had been told by a doctor that they had diabetes. Subjects
taking regular hypoglycemic medication or insulin were
considered to be on treatment for diabetes. Control of diabetes
among those with diabetes was defined as fasting plasma
glucose <7.0 mmol/l (126 mg/dl).
Inboth Astana city andAkmol village,all bloodsamples were
collected in vacutainers with coagulation activator and serum
separation gel. After blood was collected, the tubes were gently
shaken up, centrifuged and serum was separated into micro-
tubes. Cooled serum samples were delivered to Astana city, and
blood glucose concentration was measured using automatic
modular analyzer Cobas 6000, Roche Diagnostics (Germany).
We did not use fluoride plasma, since the serum measurements
have been shown to be satisfactory [17]. The maximum delay
time of the biochemical analysis was no more than 4 hours after
blood collection. The minimum fasting period was 8 hours.
Body mass index (BMI) and waist to hip ratio (WHR) were
used to assess obesity and abdominal obesity, respectively.
BMI was categorized based on WHO classification: normal
(BMI 18.5–24.9 kg/m2), overweight (BMI 25–29.9 kg/m2), and
obese (BMI over 30 kg/m2). Waist and hip circumferences were
measured with one layer of clothes using a standard tape
measure. The tape was applied halfway between the costal
margin and iliac crest to measure waist, and over the greater
trochanter to measure hip. The tape was pulled tight and
measurements were taken to the nearest 0.1 cm and recorded.
WHR was categorized into two groups based on WHO cut-off
points: abdominal obesity is defined as a waist–hip ratio above
0.90 for men and above 0.85 for women. [18]
Prior to blood pressure measurement participants were asked
to sit quietly for 5 minutes. Blood pressure was measured three
times on the right arm in the sitting position, with a two minute
interval between measurements. The average of the second
and third measurements was used inthe analyses. Hypertension
was defined as SBP 140 mmHg and/or DBP 90 mmHg, and/or
the use of antihypertensive medication in the last two weeks.
In addition to age and sex, we used the following socio-
demographic characteristics. Urban and rural locations were
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status was classified as married vs. unmarried (widowed,
divorced and single). Education was categorized into primary
or less; vocational/secondary and university. The ethnicity
was categorized as Kazakh, Russian and other. Car ownership
and three categories of household amenities ownership based
on the sum of items owned by the household (microwave, DVD
player, TV, washing machine, dishwasher, freezer, second
house ‘‘dacha’’, video camera, cable TV, land phone, mobile
phone) were used as markers of material conditions.
2.3. Statistical analysis
In descriptive analyses, unadjusted frequencies of all covari-
ates were stratified by region (urban or rural). The crude
distribution of all outcomes (diabetes prevalence, awareness,Table 1 – Descriptive characteristics of the study sample by u
Variable name Astana city (ur
Total number of participants N = 478 
Sex, (%)
Men 46.7% 
Women 53.4% 
Fasting plasma glucose, mean (SD) 5.81 (2.27) 
Fasting plasma glucose >= 7 mmol/l, (%) 9.8% 
Hypertension, (%) 70.6% 
Systolic BP, mean (SD), mmHg 135.0 (22.8) 
Diastolic BP, mean (SD), mmHg 87.8 (13.7) 
BMI, mean (SD), kg/m2 29.8 (4.9) 
BMI categories, (%)
18.50 - 24.99 kg/m2 (normal) 16.0% 
25.00 - 29.99 kg/m2 (overweight) 38.2% 
Over 30 kg/m2 (obese) 45.8% 
Waist–hip ratio categories, (%)
< 0.9 in men and < 0.85 in women 18.0% 
 0.9 in men and  0.85 in women 82.1% 
Family history of diabetes among all, (%)
No 79.7% 
Yes 20.3% 
Age, mean (SD) 61.2 (7.3) 
Age groups, (%)
50-54 25.6% 
55-59 20.5% 
60-64 22.1% 
65-69 16.2% 
70-75 15.6% 
Marital status, (%)
Married 73.2% 
Unmarried 26.8% 
Education, (%)
1 primary 35.5% 
2 secondary 20.9% 
3 higher 43.6% 
Car ownership, (%)
No 38.5% 
Yes 61.5% 
Ethnicity, (%)
Kazakhs 57.8% 
Russians 25.9% 
Others 16.3% 
Household possessions, (%)
1 Low score (1-6) 13.5% 
2 Intermediate score (7-8) 36.5% 
3 High score (9-11) 50.0% treatment and control) was shown by region and sex. The
association between each outcome and covariate (socio-
economic characteristics, BMI, WHR, hypertension and family
history of diabetes) were estimated using logistic regression
adjusted for age and sex. A final model for each outcome
adjusting for all covariates was also estimated. All analyses
were performed using STATA software, version 12 (College
Station, Texas, USA).
3. Results
Table 1 shows descriptive characteristics of the urban and
rural population samples. The overall prevalence of raised
fasting plasma glucose was 8.9%, 72% had hypertension and
44% were obese (no individuals were underweight in therban and rural area.
ban) Akmol village (rural) Both
N = 475 N = 953
41.7% 44.2%
58.3% 55.8%
5.28 (2.028) 5.54 (2.17)
8.0% 8.9%
73.6% 72.1%
138.4 (21.1) 136.7 (22.0)
91.8 (12.8) 89.8 (13.4)
29.2 (5.3) 29.5 (5.1)
22.2% 19.1%
35.7% 37.0%
42.1% 44.0%
38.3% 28.2%
61.7% 71.9%
91.9% 85.8%
8.1% 14.2%
60.2 (7.2) 60.7 (7.3)
28.5% 27.0%
25.4% 22.9%
19.0% 20.6%
13.6% 14.9%
13.4% 14.5%
73.8% 73.5%
26.2% 26.5%
39.0% 37.2%
45.8% 33.2%
15.2% 29.6%
50.1% 44.2%
49.9% 55.8%
58.5% 58.1%
26.9% 26.4%
14.7% 15.5%
32.2% 22.9%
50.4% 43.5%
17.4% 33.7%
Table 2 – Prevalence, awareness, treatment and control of diabetes (DM) in Astana city and Akmol village.
Men (n = 415) Women (n = 538) Both sexes (n = 953)
Prevalence 95%
CI
Cases/
All
Prevalence 95% CI Cases/
All
Prevalence 95% CI Cases/
All
Combined Astana city and Akmol village
Prevalence of diabetes among all 12.8% 9.5-16.0 53/415 12.3% 9.5-15.0 66/538 12.5% 10.4-14.6 119/953
Awareness among all cases of DM 66.0% 52.9-79.2 35/53 77.3% 66.9-87.7 51/66 72.3% 64.1-80.4 86/119
Treatment among all cases of DM 58.5% 44.8-72.2 31/53 71.2% 60.0-82.4 47/66 65.6% 56.9-74.2 78/119
Treatment among aware 85.7% 73.5-97.9 30/35 88.2% 79.1-97.4 45/51 87.2% 80.0-94.4 75/86
Control among all cases of DM 22.6% 11.0-34.3 12/53 31.8% 20.3-43.4 21/66 27.7% 19.6-35.9 33/119
Control among treated 38.7% 20.5-56.9 21/31 44.7% 29.9-59.4 21/47 42.3% 31.1-53.5 33/78
Astana city (urban)
Prevalence of diabetes among all 15.5% 10.7-20.4 34/219 17.0% 12.4-21.6 44/259 16.3% 13.0-19.6 78/478
Awareness among all cases of DM 82.4% 68.9-95.9 28/34 86.4% 75.8-96.9 38/44 84.6% 76.4-92.8 66/78
Treatment among all cases of DM 73.5% 57.9-89.2 25/34 90.9% 82.1-99.8 40/44 83.3% 74.9-91.8 65/78
Treatment among aware 89.3% 77.1-101.5 25/28 100.0% 38/38 95.5% 90.3-100.4 63/66
Control among all cases of DM 29.4% 13.3-45.5 10/34 47.7% 32.4-63.1 21/44 39.7% 28.6-50.8 31/78
Control among treated 40.0% 19.4-60.6 10/25 52.5% 36.3-68.7 21/40 47.7% 35.2-60.2 31/65
Akmol village (rural)
Prevalence of diabetes among all 9.7% 5.5-13.9 19/196 7.9% 4.7-11.1 22/279 8.6% 6.1-11.2 41/475
Awareness among all cases of DM 36.8% 13.0-60.7 7/19 59.1% 36.8-81.4 13/22 48.8% 32.8-64.8 20/41
Treatment among all cases of DM 31.6% 8.6-54.6 6/19 31.8% 10.7-53.0 7/22 31.7% 16.8-46.6 13/41
Treatment among aware 71.4% 26.3-116.6 5/7 53.9% 22.5-85.2 7/13 60.0% 36.5-83.5 12/20
Control among all cases of DM 10.5% 0.0-25.7 2/19 0.0% 0/22 4.9% 0.0-11.8 2/41
Control among treated 33.3% 0.0-87.5 2/6 0.0% 0/7 15.4% 0.0-38.1 2/13
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Fasting plasma glucose, BMI and waist-hip ratio and family
history of diabetes were higher in Astana city than in Akmol.
Higher education, car ownership and household amenity
ownership were also higher in urban vs. rural areas.
Table 2 presents the prevalence, awareness, treatment and
control of diabetes. From the total sample of 953 respondents
from Astana city and Akmol village, 119 (12.5%) were classified
as having diabetes; the proportion of subjects with diabetes
was twice as high in Astana city than in Akmol village. Among
subjects with diabetes, 72.3% were aware of their condition,
65.6% took medication, and 27.7% had fasting glucose level
controlled (i.e. fasting plasma glucose <7 mmol/l). Among
those aware of the condition, 87.2% were taking medication
(only 4 persons aware of diabetes reported to be on diet
without medication), among those taking medication, 42.3%
had controlled diabetes. Again, there were marked differences
between urban and rural areas. The prevalence of awareness
and treatment of diabetes were two times higher in urban
area. Successful control of diabetes in the rural area was very
low (4.9%) compared with the city (39.7%); the difference was
less dramatic among those aware of having diabetes (47.7% vs.
15.4%).
Table 3 shows age-sex-adjusted odds ratios for covariates
and diabetes prevalence, awareness, treatment and control.
The prevalence of diabetes was associated with higher age,
increasing body mass index, central obesity and family history
of diabetes. The odds of diabetes was less than half in rural
Akmol compared to urban Astana. The odds of awareness,
treatment and control were also substantially lower in the
rural vs. urban area. Among the socio-demographic measures,
only household items were statistically significantly associat-
ed with (increased) diabetes prevalence and control of
diabetes. In addition, Russian ethnicity had marginally
increased prevalence of diabetes.Multivariable analysis was only possible for diabetes
prevalence (Table 3, column 3), as the numbers of subjects
were too small for multivariate analysis of awareness,
treatment and control of diabetes. For diabetes prevalence,
the main difference was that the odds ratio for rural vs. urban
residence was attenuated from 0.49 increased to 0.60 (95%
confidence interval 0.37-0.99), the odds ratio for Russian vs.
Kazakh ethnicity increased to 1.59 (0.99-2.57), and the
association with BMI and central obesity were both reduced.
4. Discussion
In the present study we estimated the prevalence, awareness,
treatment and control of diabetes among middle-aged and
older residents of Astana city (urban) and Akmol village (rural)
in Kazakhstan. The overall prevalence of diabetes was 12.5%
(close to WHO estimate of 13.2%) but we detected marked
differences between urban and rural areas, with all outcome
measures being higher in urban residents. As expected,
diabetes prevalence was also positively associated with higher
age, higher BMI and WHR and family history of diabetes. There
was also a suggestion that diabetes prevalence was higher
among Russians.
Several limitations that should be taken into account when
interpreting the results. First, the diagnosis of diabetes used in
the study may be imprecise, as only one measurement of FPG
was used; for logistic and financial reasons, other markers for
diabetes diagnosis (oral glucose tolerance test and glycated
hemoglobin) were not measured. However, FPG is widely
recognized as an acceptable screening test for diabetes and a
good measure of diabetes control [19,20]
Second, the response rate was modest, although the real
response may have been higher, as some selected subjects
may not have received the invitation to participate in the study
Table 3 – Odds ratios (95% confidence intervals) for selected covariates and the prevalence, awareness, treatment and
control of diabetes.
Prevalence 1
OR (95% CI)
Prevalence 2
OR (95% CI)
Awareness 1,*
OR (95% CI)
Treatment 1,*
OR (95% CI)
Control 1,*
OR (95% CI)
Sex
Men 1 1 1 1 1
Women 0.95 (0.64-1.40) 0.80 (0.50-1.27) 2.07 (0.86-4.99) 1.82 (0.82-4.02) 1.58 (0.68-3.67)
Age groups
50-54 1 1 1 1 1
55-59 1.69 (0.95-3.00) 1.51 (0.82-2.79) 3.74 (0.84-16.76) 2.04 (0.64-6.56) 1.37 (0.39-4.90)
60-64 1.64 (0.91-2.95) 1.43 (0.75-2.72) 0.54 (0.16-1.81) 1.37 (0.43-4.42) 1.95(0.54-6.97)
65-69 1.30 (0.66-2.56) 1.07 (0.52-2.22) 1.70 (0.36-8.08) 2.12 (0.51-8.72) 1.11 (0.24-5.07)
70-75 1.98 (1.06-3.71) 1.48 (0.72-3.02) 0.50 (0.14-1.81) 0.77 (0.23-2.60) 0.93 (0.22-3.89)
Urban/Rural
Astana 1 1 1 1 1
Akmol 0.49 (0.32-0.73) 0.60 (0.37-0.99) 0.12 (0.05-0.34) 0.08 (0.03-0.20) 0.08 (0.02-0.34)
BMI
18.5-24.9 1 1 1 1 1
25-29.9 2.66 (1.15-6.16) 1.61 (0.67-3.86) 1.71 (0.27-11.07) 0.41 (0.06-2.69) 0.58 (0.08-4.04)
30 6.19 (2.77-13.85) 3.13 (1.33-7.40) 1.64 (0.28-9.73) 0.53 (0.09- 3.26) 0.81 (0.13-5.17)
WHR, obesity
No 1 1 1 1 1
Yes 5.39 (2.67-10.87) 4.19 (1.93-9.12) 2.73 (0.61-12.17) 1.96 (0.47-8.20) 1.23 (0.23-6.55)
Hypertension
No 1 1 1 1 1
Yes 1.50 (0.93-2.43) 1.19 (0.70-2.01) 0.93 (0.31-2.81) 0.75 (0.27-2.08) 0.44 (0.16-1.20)
Family history
No 1 1 1 1 1
Yes 2.19 (1.35-3.54) 1.58 (0.93-2.68) 3.43 (0.89-13.17) 1.57 (0.57-4.33) 1.60 (0.61-4.20)
Marital status
Married 1 1 1 1 1
Unmarried 1.02 (0.63-1.64) 0.90 (0.53-1.54) 1.80 (0.56-5.81) 2.80 (0.93-8.39) 1.91 (0.65-5.56)
Education
1 Primary 1 1 1 1 1
2 Vocational 0.65 (0.41-1.05) 0.68 (0.41-1.15) 0.50 (0.18-1.39) 0.34 (0.13-0.91) 0.65 (0.22-1.90)
3 Higher 0.87 (0.55-1.39) 0.68 (0.40-1.15) 2.44 (0.66-9.07) 2.34 (0.74-7.39) 1.23 (0.45-3.40)
Ethnicity
Kazakh 1 1 1 1 1
Russian 1.48 (0.96-2.30) 1.59 (0.99-2.57) 1.28 (0.49-3.35) 0.80 (0.33-1.94) 1.74 (0.69-4.41)
Other 1.11 (0.63-1.97) 0.80 (0.43-1.49) 1.84 (0.48-7.08) 1.48 (0.44-5.01) 1.44 (0.42-4.95)
Car ownership
yes 1 1 1 1 1
no 1.27 (0.84-1.90) 1.09 (0.67-1.78) 0.94 (0.36-2.42) 1.03 (0.44-2.41) 1.63 (0.67-3.96)
Possessions
1 Low 1 1 1 1 1
2 Medium 1.60 (0.90-2.84) 1.30 (0.69-2.43) 0.21 (0.04-1.02) 0.38 (0.10-1.38) 0.20 (0.05-0.83)
3 High 1.92 (1.07-3.46) 1.08 (0.53-2.20) 0.53 (0.11-2.56) 1.19 (0.31-4.58) 1.93 (0.55-6.74)
1 adjusted for age, 2 adjusted for all variables in table, * among persons with diabetes
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been suggested that 60% response rate is satisfactory [21] and
response rates similar to our study are common for recent
studies in Europe and elsewhere but some at least selection
bias is likely. Typically, participants in epidemiological studies
usually have higher socio-economic status and better health
than non-participants [22]. It is also possible that a study based
in polyclinics may have attracted less healthy patients with
perceived higher need for medical care. Therefore, the lower
response rates may lead to both under- and overestimation of
diabetes prevalence. However, since response rates were
higher in women and in older age groups, some overestima-
tion of diabetes prevalence is possible. The response rates
were slightly higher in Astana but the difference was not large
enough to introduce serious selection bias.Third, the rural and urban areas in this study were chosen
for practical reasons. Astana is a modern capital city, with a
large proportion of civil servants and well educated popula-
tion. Akmol, although rural, it is relatively close to Astana and
it is possible that more remote areas would show even more
extreme differences from Astana. Finally, the survey had a
relatively small sample size and especially among persons
with diabetes (only 119 subjects) the statistical power to detect
associations with covariates was very low.
On the other hand, it is reassuring that high BMI, high
WHR and family history of diabetes were associated with
diabetes, in a manner consistent with published studies.
[23,24] This supports the validity of the diabetes classifica-
tion used in this paper and generally suggests a good quality
of the data.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 1 2 ( 2 0 1 6 ) 6 – 1 2 11To our best knowledge there were no previously pub-
lished studies on the awareness, treatment and control of
diabetes in Kazakhstan, and there is only limited evidence in
other Central Asian republics. [5,6] The high levels of
awareness, treatment and control of diabetes in this study
are similar to previously reported levels of these indices for
hypertension in the Astana city [25]. This pattern of high
awareness and treatment are likely to reflect the affluent
and better educated population in Astana city with good
access to health care.
The high levels of diabetes indices in our study are similar
to recently published estimates for other low- and middle-
income countries [26,27]. For example, data from India suggest
a prevalence of diabetes among older persons of 16%, and
levels of awareness, treatment and control of 72%, 54%, and
40%, respectively. [28] In the US, as an example from a high
income country, the estimates in elderly population were even
higher, with a prevalence of 21% and awareness, treatment
and control reported as 71%, 51% and 50%, respectively. [29]
The inclusion of the rural Akmol village into this study
revealed a huge gap between two populations. All diabetes
indices were several times lower in Akmol village than in the
capital city. Interestingly, awareness was very low and there
were very few cases of controlled diabetes in the rural area.
Although there are no reliable data on levels and distribution
of lifestyle factors in Kazakhstan, the high prevalence of
diabetes, obesity and hypertension in Astana city may reflect
the urbanised and affluent life style, with easily available
elements of westernised diet and high density to fast food
outlets is consistent with higher rates of different non-
communicable diseases in urban vs. rural areas reported
from other Asian populations in lower and middle income
countries [13,14]. Although obesity was common in both urban
and rural areas in our study, the mean BMI and the prevalence
of obesity were higher in Astana than in the rural area. It is
possible that rapid urbanization, introduction of western life
style and economic development in Kazakhstan are associat-
ed with accelerated nutrition transition, as seen in other
populations [30].
Regarding the social and economic determinants of
diabetes indices, residence in an urban or rural setting exerted
the greatest influence. Surprisingly, we found only modest
differences in diabetes prevalence by education and car
ownership; in addition, in age-sex-adjusted analyses, higher
household item ownership was associated with increased
odds of prevalent diabetes. This pattern may potentially
reflect the current position of Kazakhstan in terms of
epidemiological and nutritional transition. There is evidence
that the social gradient in obesity changes with affluence and
development; at earlier stages of transition, obesity shows a
positive association with socioeconomic status but at later
stages the gradient becomes inverse. [31]
The higher prevalence of diabetes in ethnic Russians is
analogous to previously reported lower self-rated health in the
Russian vs. Kazakh ethnicity [32,33], however, in contrast to
self-rated health, the difference for diabetes prevalence was
only marginally statistically significant. While the increased
risk in Russians may be related to life style of socioeconomic
status, it was not attenuated in the fully adjusted model.
Persons with high education had a clear advantage in terms ofawareness, treatment and control of diabetes; this pattern
most likely reflects the better access to health care.
In summary, this study showed relatively high prevalence of
diabetes in this Kazakhstan population sample, with large
differencesinalldiabetesindicesbetweenurbanandruralareas.
These results require confirmation in a larger study, preferably
using a large number of urban and rural areas. If confirmed,
the urban/rural differences suggest a need for a diabetes
screening and management programme, focusing on access
to health care in rural areas and on prevention in the cities.
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